Evercore 'Not Overly Surprised' by Edwards' (EW) Acquisition of Valtech's Cardioband; Affirms at 'Hold'

November 28, 2016 2:01 PM EST Send to a Friend
Evercore ISI affirms Edwards Lifesciences (NYSE: EW) witha Hold rating and $105 price target after the company announced that it ...

To continue reading this article and more like it please sign-in or join today (FREE!)

Member Login